Treatment of Stage IE / Stage IIE Primary Pulmonary Diffuse Large B-Cell Lymphoma (DLBCL)

Primary pulmonary lymphoma (PPL) presenting at stage IE or stage IIE as diffuse large B-cell lymphoma (DLBCL) represents a distinct clinical scenario within pulmonary lymphomas, and the evidence-based treatment approach for this subtype differs from that of other PPL subtypes.

Clinical scenario Stage IE or stage IIE primary pulmonary DLBCL — disease localised to the lung, with or without regional nodal involvement. Evidence supports a surgical approach specifically for this histological subtype; this recommendation does not extend to stage IE/IIE MALT lymphoma, other non-Hodgkin lymphomas, or Hodgkin lymphoma arising in the lung.

Treatment approach (partial overview) The structured protocol for stage IE/IIE primary pulmonary DLBCL incorporates surgical resection of the pulmonary lesion together with chemotherapy. The specific surgical approach, extent of resection, sequencing, and full chemotherapy details are defined within the complete evidence-based regimen — access it below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.21037/jtd-24-1524

View source ↗